Lotus Pharmaceutical Co., Ltd. (1795.TW)

323.00 -6.00 (-1.82%) At close: 01:30PM CST

Lotus Pharmaceutical Co., Ltd.

No. 277 Song Ren Road
17th Floor Xin Yi District
Taipei 110
Taiwan
886 2 2700 5908
https://www.lotuspharm.com.tw

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Petar Antonov Vazharov	CEO & Director	34.72M	N/A	N/A
Mr. Zenon Zdunek	Vice President of Supply Chain & Operations	12.83M	N/A	N/A
Ms. Eeling Chan	Chief Financial Officer	5.19M	N/A	N/A
Ms. Gwen Hsieh	Chief Information Officer	N/A	N/A	N/A
Ms. Yu-Ying Yang	Associate Director of Co-Operate Communication	N/A	N/A	N/A
Boon Chong Tan	Deputy General Manager	N/A	N/A	N/A
Mr. Edin Buljubasic	Vice President	N/A	N/A	N/A
Yingming Yue	Vice President	N/A	N/A	N/A
Valerie Lau	Chief Commercial Officer-APAC	N/A	N/A	N/A
Mr. Manish Chawla	Vice President of Research and Development	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.

Description

Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, women's health, anti-obesity, and central nervous system diseases. The company also provides over-the-counter products. In addition, it engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. Further, the company offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. The company has strategic partnership with NRX Pharmaceuticals. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.

Corporate governance

Lotus Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.